Wells Fargo analyst Stephen Baxter maintained a Buy rating on CVS Health (CVS – Research Report) on March 14 and set a price target of $73.00.
The retailer’s US operating company filed for bankruptcy Sunday, for the second time in six years, citing fierce competition from foreign fast fashion retailers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback